About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 2

Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

NCT02464878•Massachusetts General Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Kidney TransplantType 1 Diabetes

Interventions

Alpha 1-Antitrypsin

Islet Transplantation

+3 more

Locations

1

United States

Locations (1)

Massachusetts General Hospital

Boston, Massachusetts, United States

Key Dates

Start Date

January 1, 2017

Primary Completion Date

November 1, 2022

Completion Date

December 1, 2022

Last Updated

December 22, 2023

Related Studies

RECRUITINGPhase 2

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children

NCT05753930

Kidney Transplantation in Highly Sensitized Patients

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321

Type 1 Diabetes Mellitus

RECRUITINGEARLY Phase 1

Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

NCT07395050

Stage 3 Type 1 Diabetes

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

NCT07457580

Type 1 Diabetes

RECRUITINGPhase 2

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

NCT06059664

Kidney Transplant; Complications

Capillary OGTT Study

NCT06815081

Type 1 Diabetes (T1D)Type 2 Diabetes

View all related studies

Sponsors

Lead Sponsor

Massachusetts General Hospital

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of Iowa

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 22, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions